Skip to Content

Interferon Alfa-2a

In the US, Interferon Alfa-2a (interferon alfa-2a systemic) is a member of the drug class antineoplastic interferons and is used to treat Chronic Myelogenous Leukemia, Hairy Cell Leukemia, Hepatitis C, Kaposi's Sarcoma, Lymphoma and Renal Cell Carcinoma.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antineoplastic agent

Antiviral agent: Treatment of hepatitis

Biological response modifier, BRM


Foreign Names

  • Interferonum alfa-2a (Lys-23; His-34) (Latin)
  • Interferon alfa-2a (Lys-23; His-34) (German)
  • Interféron alfa-2a (Lys-23; His-34) (French)
  • Interferón alfa-2a (Lys-23; His-34) (Spanish)

Generic Names

Brand Names


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.